A.J.M. van den Eertwegh
2 clinical trials · Sponsor
◉ Watch A.J.M. van den Eertwegh
| Record | Firm | Date |
|---|---|---|
| A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (NCT04126876) | A.J.M. van den Eertwegh | 2020-01-22 |
Track A.J.M. van den Eertwegh automatically
Every clearance here is in the API, with alerts when new ones post.